Background
Human alpha interferons ( Hu IFN α ) comprise a multigene family, originally identified as proteins responsible for the induction of cellular resistance to viral infections, subdivided into 13 different subtypes (IFN α1, α2, α4, α5, α6, α7, α8, α10, α13, α14, α16, α17 and α21 ). The genes that encode these proteins are clustered on chromosome 9 in human [1] . There have been reports of obvious differences in the relative biologicals activities among IFN α subtypes [2, 3] and it was found that the activity varied greatly depending on the target cells, the IFN α subtypes and even if the proteins were compared on base of both units of biological activity or mass [4] . The Hu IFN α2b and Hu IFN α8 are among the IFN subtypes with highest antiviral activity. The first one was licensed by the Food and Drug Administration in 1986 (USA) for the treatment of hairy cell leukemia [5] . On the other hand, the Hu IFN α8 has shown the highest biological activity in several in vitro assays [6] [7] [8] .
Several progresses in the fundamental understanding of transcription, translation, and protein folding in Escherichia coli, together with the availability of improved genetic tools (including new mutants) are making this bacterium more valuable than ever for the expression of complex eukaryotic proteins. Several strategies have been required to enhance rare codons gene expression [9, 10] .
Homogenous Hu IFN α preparations were originally obtained in 1978 for further chemical and physical characterization [11] . Thereafter have been introduced new high performance chromatography techniques useful to obtain enough quantity of these proteins for their chemical, biological and immunological studies [12] . Although high quantities of these proteins could be obtained, these procedures involve costly and laborious purification protocols.
In our previous report we attempted to over express the Hu IFN α8 in E. coli without success [13] . In the present work, the heterologous expression of both Hu IFN α8 and Hu IFN α2b was significantly improved. These proteins were purified by one step and low cost SDS-PAGE procedure and used for detailed chemical and physic characterization. Both Hu IFN α subtypes obtained were used to compare its antiviral activity by using an in vitro model involving Hep-2 cells challenged with Mengo virus [14] .
Results
Comparing the rare codon compositions of both Hu IFN α subtypes, two clusters of 30 amino acids, containing five minor triplets, were found (see Figure 1 ). For the Hu IFN α2b gene, the minor codons, represented only by AGG/AGA (that encodes for Arg) are present in both clusters. However, besides the minor triplets that encodes for Arg, in the Hu IFN α8 gene one minor codon AUA (ATA triplet, that encodes for Ile) is present in the first cluster, while in the second one, the CUA (CTA triplet, that encodes for Leu) exists. <supplement> <title> <p>The 4th Recombinant Protein Production Meeting: a comparative view on host physiology</p> </title> <sponsor> <note>The organisers would like to thank Novozymes Delta Ltd who generously supported the meeting.</note> </sponsor> <note>Meeting abstracts -A single PDF containing all abstracts in this supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1475-2859-5-S1-full.pdf">here</a></note> <url>http://www.biomedcentral.com/content/pdf/1475-2859-5-S1-info.pdf</url> </supplement> Taking into account the minor codon composition in both Hu IFN α genes, E. coli BL21-codonplus-RIL cells (Stratagene, USA) were used to increase the heterologous polypeptides expression levels. E. coli BL21-codonplus-RIL cells were transformed with the plasmids pALF8-4 and pAGUA-4 [13] coding for Hu IFN α8 and Hu IFN α2b , respectively. This strain carries out additional copies of the dnaY, ileY and leuW t RNAs in an additional Cm r pACYC derivative plasmid. The last two tRNA decode the AUA and CUA minor codons, respectively. The obtained transformants were grown in M9 minimum medium. For Hu IFN α8 transformants, the protein expression level increased from 1% (with E. coli BL-21/pALF8-4) up to 25% (with E. coli BL-21 CP RIL/pALF8-4) of total bacterial proteins based on densitometric analysis of scanned gels (see Figure 2) . Similar results were obtained with the Hu IFN α2b Amp r -Cm r transformants, the expression levels increased from 5% (with E. coli BL-21/pAGUA-4) up to around 20% (with E. coli BL-21CPRIL/pAGUA-4) of total host proteins.
The purity of purified Hu IFN α subtypes was estimated over 98%, based on the homogeneity observed in the silver Expression of both Hu IFN α subtypes in E. coli cells grown in minimum media Clusters of 30 aminoacid presents in both Hu IFN α subtypes Figure 1 Clusters of 30 aminoacid presents in both Hu IFN α subtypes. In boxes, the AGA/AGG triplets coding for Arginine. The ATA and CTA triplets coding for Isoleucine and Leucine, respectively, are underlined.
stained SDS-PAGE and by RP-HPLC analysis (see Figure  3 ).
The antiviral potency of both Hu IFN α subtypes was compared in an in vitro assay with one microgram of each protein challenged with mengo virus [14] . Results of five independent experiments are shown in the 
The titer values are expressed in 10 6 international units. nd, not antiviral activity detectable. a Values in parenthesis correspond to confidence limits (p < 0.05).
Conclusion
In summary, this work highlights several issues to obtain human proteins with high molecular homogeneity avoiding costly and tedious purification procedures. Therefore, we recommend this experimental strategy to obtain humans proteins with high therapeutic potentials. The highest antiviral activity of Hu IFN α8 shown in vitro add new evidences to take into account this proteins as strong therapeutic candidate.
